Disclaimer: This is not investment advice. PLEASE DO YOU OWN RESEARCH !!!
What a difference a year can make. Less than a year ago, I tried to enlarge my circle of incompetence by looking at BioNTech. This was my summary back then:
I have to admit that some “fear of regret” plays a role here. i would deeply regret not to have invested if this becomes an even bigger success. Therefore I decided to invest “only” 2% of the portfolio into BioNTech within my “Long term growth bucket” at around 98 EUR/share, reflecting the inherent risk at this stage.
My game plan would be to hold this at least 2-3 years and only consider to sell if the stock drops for no reason by more than -50% or goes up by more than +100%.
I expect very positive results both, for 2021 and 2022, however after than, vaccine sales will clearly go down and then it needs to be seen how the cancer pipeline works out or if they can come up with more vaccines.
If initial pipeline would become more concrete and the valuation still makes sense, I might increase the position in 2 or 3 years from now. In between, the position will motivate me to learn more about mRNA and Biotech in general, which is a nice side effect.
In between the stock did hit a peak of ~390 EUR in August 2021, I.e. almost quadrupling from the level that I bought before falling back sharply to a level EUR 150 at the time of writing
I did actually sell 30% of my position at prices between 270-300 at the end of July, getting back my invested money (before taxes).
The big question is: What to do now ?
2021 was a (for me) surprisingly strong year for equity markets with double digit growth across many equity markets.
In 2021, the Value & Opportunity portfolio gained +22,5% (including dividends, no taxes) against +18,5% for the Benchmark (Eurostoxx50(25%), Eurostoxx small 200 (25%), DAX (30%), MDAX (20%), all performance indices including Dividends).
Links to previous Performance reviews can be found on the Performance Page of the blog. Some other funds that I follow have performed as follows in 2020:
Partners Fund TGV: +38,2% (30.12.)
Profitlich/Schmidlin: +20,0% (30.12.)
Squad European Convictions (30.12.) +25,0%
Ennismore European Smaller Cos (30.12.) +23,1% (in EUR)
Frankfurter Aktienfonds für Stiftungen (30.12.) +17,3%
Greiff Special Situation (30.12.) +5,5,%
Squad Aguja Special Situation (30.12.) +5,4%
Paladin One (30.12.) +14,6%
Following an annual tradition once a year I’ll try to review my current portfolio by writing short summaries/update for each individual position. Unfortunately, I didn’t manage to do this before year end in 2021, but better late than never.
This year, 17 of the 27 companies from last year are still in the portfolio and I have 11 new positions which again looks like quite high turnover. Again, part of that high turnover is driven by “killing” the travel basket and creating a new “Energy Transition /Electrification” basket.
Overall, the number of positions is on the upper end of my preferred range of 20-30 titles. So any new investments will need to be financed through a sale of existing positions.
The summaries of the previous years can be found here:
My 21 (+6) Investments for 2021
My 20 investments for 2020
My 22(+1) Investments for 2019
My 21 investments for 2018
My 27 investments for 2017
My 27 investments for 2016
My 28 investments for 2015
My 24 investments for 2014
My 22 investments for 2013
1. TFF Group (6,0%)
Introduction: Why looking at Crypto at all ?
I had written first about Bitcoin in September 2016, when 1 Bitcoin was around 1000 USD. I always had an academic interest because the original idea and the execution of a decentralized decision making system has been a great achievement in itself. You’ll find an attempt to describe Bitcoin and Blockchain here from September 2017.
In November 2017 I made the following observation:
In my opinion, the current Cryptocraze is much more like the South Sea bubble than the Tulip mania.
Underlying the current Crypto currency mania in my opinion is a fundamental new way how to raise capital for and create a new type of decentralized organization.
Clearly the then prominent ICOs were mostly complete garbage or outright theft, such as Wysker or the Naga Coin.
However, four years later, Crypto is booming again and the big currencies are more “valuable” than ever before and there is a “Cambrian explosion” of activity all over the Crypto space.
So I decided to have another look at the Crpyto mainly to educate myself on new Crypto currencies but also on “second generation” activities such as Staking, DAOs, DeFi and NFTs.
Maybe it is of interest to some readers, maybe not, but I do think it makes sense to understand a little bit the evolution in this space. Just to be clear: I don’t think that the space is “investable” as such, however part of the infrastructure that is created now might have impacts on other parts of the economy and society.
So let’s kick it off with looking at the main 20+ Crypto currencies according to “market cap” according to coinmarketcap.com.
Every year on December 15th, the blog celebrates another anniversary, because on that day in December 2010, the blog went live for the first time. (Edit: This should have gone out yesterday….).
As always there will be a separate performance portfolio review in the beginning of Januray. This time, it is the 11th. I have googled around a little bit and the Number 11 seems to mean sometimes achieving a higher spiritual level. I am not sure if I managed this in my 11th year in the blog, although I feel strangely relaxed about the recent market turbulences 😉
Again, a big thank you to all readers, especially those who contribute (and motivate) via constructive comments but of course also to all the silent readers.
The top 10 posts in 2021 were the following: